Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5
about
Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromesRoles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseasesRegulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases.Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.Distinct and shared roles of β-arrestin-1 and β-arrestin-2 on the regulation of C3a receptor signaling in human mast cells.Regulation of Fc∈RI signaling in mast cells by G protein-coupled receptor kinase 2 and its RH domain.Complement anaphylatoxins as immune regulators in cancer.Phosphorylation of C3a receptor at multiple sites mediates desensitization, β-arrestin-2 recruitment and inhibition of NF-κB activity in mast cellsRoles for NHERF1 and NHERF2 on the regulation of C3a receptor signaling in human mast cellsComplement deficiency promotes cutaneous wound healing in mice.G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2.Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?Peripheral basophil reactivity, CD203c expression by Cryj1 stimulation, is useful for diagnosing seasonal allergic rhinitis by Japanese cedar pollen.Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.Induction of complement C3a receptor responses by kallikrein-related peptidase 14.Anaphylaxis: past, present and future.Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.Current state of biology and diagnosis of clonal mast cell diseases in adults.Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?Molecular basis for downregulation of C5a-mediated inflammation by IgG1 immune complexes in allergy and asthma.Anaphylaxis as a clinical manifestation of clonal mast cell disorders.Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase.The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement.Complement components (C3, C4) as inflammatory markers in asthma.Proteinases, Their Extracellular Targets, and Inflammatory Signaling.The "ins and outs" of complement-driven immune responses.C5a receptor enables participation of mast cells in immune complex arthritis independently of Fcγ receptor modulation.Increased serum complement C3 and C4 concentrations and their relation to severity of chronic spontaneous urticaria and CRP concentration.Mechanisms Involved in Hypersensitivity Reactions to Polysulfone Hemodialysis Membranes.Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.Suggested Mechanisms of Tracheal Occlusion Mediated Accelerated Fetal Lung Growth: A Case for Heterogeneous Topological Zones.Biphasic activation of complement and fibrinolysis during the human nasal allergic response.
P2860
Q28078468-2996BD39-FC7C-4A2E-9134-A6C1A18963C9Q28079028-F3C84A68-C8A7-4A91-A310-98799EC79D1FQ31028372-BFCF2574-B833-4DCF-BE33-324F8495D5CFQ33625259-62576504-8303-4934-B2E8-DA5CE49757B0Q33903905-230B898A-2F04-43B2-BE99-941BF3DF5B75Q33947182-3E90AA47-8111-4445-A1A2-05EC66BFFF61Q34414162-BB57D212-F8DE-4FE7-99B6-0228EB3A431BQ34450340-2974388E-5803-427C-9438-D050B64419F1Q34531811-9509FC66-303F-454E-A1BB-C5F821048AADQ34980307-B9FA736A-4EB8-4AF2-AF8F-7ACFD6721A4BQ35202333-5FEF399D-F332-4BD7-B3A2-C4492A2F55ECQ36013705-15A24D11-811C-4D3E-8BC7-7E0D0EC13554Q36082339-ED0F2158-FEDB-4BF3-83C1-FAA9244BDD03Q36685067-C6A664D4-470E-4DD4-ACD9-E22E0ED2DAE2Q37579925-66199C2D-696A-458C-A95F-189463BD9985Q37766252-5E349AF6-9C9D-416D-A31C-090F6D0F7530Q37873485-70EEC6C3-BA2E-46D2-9F76-11BC24385FEDQ38007005-DB7F3BC2-584E-4B61-B56A-33D3BA503D52Q38109057-C37BB0D1-C99F-46B7-A1D9-9DAA2BE412C3Q38135285-CFE75683-D484-4714-87B0-62ACD4EE769FQ38221739-22969FCE-B2F8-44DB-A578-139BA203C739Q38755354-1065A112-AACF-4A43-B1E0-A8F0F4F12420Q38817069-542F442B-4664-4C27-9776-498CD2BCFF00Q38853733-9B8B3FAA-BCFC-446D-8AED-315DCE64D09BQ38966192-D571D749-29EA-45E7-9FCD-4CC469340E92Q38991066-1096D446-B6C7-4E98-8168-F1CE79CED090Q41831768-5A5FB94D-DC90-4C5B-8D2D-82B695A1E432Q42151210-E047789A-0220-427A-9A6E-E615015B3185Q42512549-D36D4B69-D72D-428C-A973-11EBF1186BD9Q48502611-25F5593F-A7CD-4AB5-BAF5-A9920E8ABF9AQ49627201-9EB71B03-F1BE-4D5D-8A16-3298923D1369Q50086913-C85436D8-AA6D-4AED-8532-25EB49A0222D
P2860
Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5
@ast
Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5
@en
type
label
Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5
@ast
Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5
@en
prefLabel
Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5
@ast
Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5
@en
P2093
P2860
P1476
Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5
@en
P2093
Anthony L Dellinger
Han-Zhang Xia
Laura B Sanchez-Muñoz
Lawrence B Schwartz
Luis Escribano
Yoshihiro Fukuoka
P2860
P304
P356
10.4049/JIMMUNOL.180.9.6307
P407
P577
2008-05-01T00:00:00Z